Home > Products > Novel inhibitors
Cat. No. Product name CAS No.
DCC5387 Vbit-3

Novel inhibitor of VDAC1 oligomerization and apoptosis

DCC5388 Vch-759

Novel non-nucleoside inhibitor of HCV RNA-dependent polymerase

1001913-13-8
DCC5389 Vchcaγ Inhibitor 40

Novel selective inhibitor of the γ-class enzyme of bacteria Vibrio cholerae A (VchCAγ)

DCC5390 Vd11-4-2

Novel potent and selective CA IX inhibitor

DCC5391 Vd12-09

Novel potent and selective CA IX inhibitor

DCC5392 Vdr Modulator C4

Novel nonsecosteroidal vitamin D receptor (VDR) modulator, enhancing pancreatic cancer therapy through remodeling of the tumor microenvironment by combination with gemcitabine

DCC5393 Vdr Modulator I5

Novel nonsecosteroidal vitamin D receptor (VDR) modulator, enhancing pancreatic cancer therapy through remodeling of the tumor microenvironment by combination with gemcitabine

DCC5394 Vdr Modulator I8

Novel nonsecosteroidal vitamin D receptor (VDR) modulator, enhancing pancreatic cancer therapy through remodeling of the tumor microenvironment by combination with gemcitabine

DCC5395 Ve-465

Novel Aurora kinase inhibitor

639089-73-9
DCC5396 Vegfr-in-v

Potent, Vascular Endothelial Growth Factor Receptor-​2 (VEGFR-2) Tyrosine Kinase Inhibitor

861874-34-2
DCC5397 Veledimex

Activator for Proprietary Gene Therapy Promoter System

1093130-72-3
DCC5398 Venlafaxine

Serotonin-norepinephrine reuptake inhibitor (SNRI); Antidepressant

93413-69-5
DCC5399 Ver-246608

Novel pan-isoform ATP competitive inhibitor of pyruvate dehydrogenase kinase, disrupting Warburg metabolism and inducing context-dependent cytostasis in cancer cells

1684386-71-7
DCC5400 veratramine Hydrochloride

Antitumor agent

1258005-82-1
DCC5401 Veratridine

Natural Janus-Faced Modulator of Voltage-Gated Sodium Ion Channels, acting on the channel as either an agonist or antagonist depending on the nature of the electrophysiological stimulation protocol

71-62-5
DCC5402 Verminoside

Natural anti-inflammatory and antioxidant agent, inhibiting both iNOS expression and NO release in the LPS-induced J774.A1 macrophage cell line, enhancing protein expression levels of PARP-1 and p53, and attenuating intracellular ROS and stress (oxidative

50932-19-9
DCC5403 Vernakalant

Novel blocker of atrial potassium channels

794466-70-9
DCC5404 Vernolepin

Natural Reversible Plant Growth Inhibitor

18542-37-5
DCC5405 Verticilide

Natural insect ryanodine receptor (RyR) antagonist

693778-57-3
DCC5406 Verticillin A

Apoptosis inducer, inhibiting Leiomyosarcoma and Malignant peripheral nerve sheath tumor growth

889640-30-6
DCC5407 Vesamicol Hydrochloride

Potent inhibitor of acetylcholine transport

22232-64-0
DCC5408 Vesiculopolin B

Novel anti-vesiculoviral agent, inhibiting transcription initiation of vesiculoviruses

Page 1467 / Total 1558 FirstPrevNextLastGoto